POLUZZI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 160
AS - Asia 84
EU - Europa 37
Continente sconosciuto - Info sul continente non disponibili 17
SA - Sud America 11
AF - Africa 1
Totale 310
Nazione #
US - Stati Uniti d'America 150
BD - Bangladesh 43
IT - Italia 35
SG - Singapore 13
CN - Cina 10
BR - Brasile 9
CA - Canada 4
PK - Pakistan 4
PH - Filippine 3
VN - Vietnam 3
IN - India 2
TR - Turchia 2
TT - Trinidad e Tobago 2
AR - Argentina 1
BH - Bahrain 1
BZ - Belize 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
FR - Francia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NG - Nigeria 1
NL - Olanda 1
UZ - Uzbekistan 1
Totale 293
Città #
San Jose 42
Council Bluffs 17
New York 15
Singapore 13
Ashburn 12
Los Angeles 8
Turin 5
Dallas 4
Milan 4
Rome 3
Buffalo 2
Charlotte 2
Dhaka 2
Philadelphia 2
Alexandria 1
Alhambra 1
Almaty 1
Ankara 1
Antigo 1
Araraquara 1
Arlington 1
Aversa 1
Baltimore 1
Bari 1
Barrie 1
Bauru 1
Belize City 1
Belo Horizonte 1
Bishkek 1
Bologna 1
Bra 1
Broken Arrow 1
Calgary 1
Carros 1
Cebu City 1
Columbia 1
Corona 1
Desio 1
Divinópolis 1
Durazzano 1
Durham 1
El Paso 1
Faisalabad 1
Figino 1
Fort Wayne 1
Gaziantep 1
Giffone 1
Hanoi 1
Holyoke 1
Houston 1
Hyderabad 1
Islamabad 1
Jackson 1
Kansas City 1
Kartārpur 1
Kingston 1
Lagos 1
Lahore 1
Manama 1
Mauá 1
Meadville 1
Medellín 1
Memphis 1
Miami Beach 1
Miano 1
Milwaukee 1
Modena 1
Montes Claros 1
Montreal 1
New Orleans 1
Newport News 1
Nova Friburgo 1
Não-Me-Toque 1
Orán 1
Oswego 1
Parsippany 1
Pasadena 1
Paterson 1
Peoria 1
Pittsburgh 1
Pomona 1
Port of Spain 1
Providence 1
Rizal 1
San José 1
San Pablo 1
San Valentino Torio 1
Santo Domingo Este 1
Savannah 1
Seregno 1
Surprise 1
Suzhou 1
Tashkent 1
The Woodlands 1
Toronto 1
Tucano 1
Tulsa 1
Tunapuna 1
Upper Marlboro 1
Venice 1
Totale 217
Nome #
Dipeptidyl peptidase-4 inhibitors and heart failure: Analysis of spontaneous reports submitted to the FDA Adverse Event Reporting System 38
Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis 28
Assessment of adverse reactions to α-lipoic acid containing dietary supplements through spontaneous reporting systems 25
Comparing the Prevalence of Polypharmacy and Potential Drug-Drug Interactions in Nursing Homes and in the Community Dwelling Elderly of Emilia Romagna Region 24
Diabetes is associated with decreased migraine risk: A nationwide cohort study 23
Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System 20
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting System 19
Occurrence of Multiple Sclerosis After Drug Exposure: Insights From Evidence Mapping 19
Use of antidepressants and the risk of Parkinson's disease in the Local Health Trust of Bologna: A historical cohort study 18
Crystal nephropathy and amoxicillin: insights from international spontaneous reporting systems 16
Drug-induced Kounis syndrome: A matter of pharmacovigilance 16
Serious Cutaneous Toxicities with Immune Checkpoint Inhibitors in the U.S. Food and Drug Administration Adverse Event Reporting System 14
Impact of nephrotoxic drugs on urinary biomarkers of renal function in very preterm infants 13
Biomarkers of Kidney Injury in Very-low-birth-weight Preterm Infants: Influence of Maternal and Neonatal Factors 13
Drug-induced systemic lupus erythematosus: Should immune checkpoint inhibitors be added to the evolving list? 10
Pulmonary Embolism in a Patient With ADPKD Treated With Tolvaptan: From the Clinical Experience to the Analysis of the Food and Drug Administration Adverse Event Reporting System Registry 8
The Contribution to the Assignment of Defined Daily Dose (DDD) to Antineoplastic Drugs of the Italian Working Group on DDD 6
Totale 310
Categoria #
all - tutte 1.545
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.545


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2025/2026268 0 0 0 0 0 0 0 0 70 87 57 54
2026/202742 15 27 0 0 0 0 0 0 0 0 0 0
Totale 310